Odisha News, Odisha Latest news, Odisha Daily - OrissaPOST
  • Home
  • State
  • Metro
  • National
  • International
  • Business
  • Opinion
  • Feature
  • Timeout
  • Entertainment
  • Sports
  • Sci-Tech
  • Others
    • COVID-19
    • Today’s Pic
  • Home
  • State
  • Metro
  • National
  • International
  • Business
  • Opinion
  • Feature
  • Timeout
  • Entertainment
  • Sports
  • Sci-Tech
  • Others
    • COVID-19
    • Today’s Pic
No Result
View All Result
OrissaPOST - Odisha Latest news, English Daily -
No Result
View All Result

COVID Vaccine: PGI-Chandigarh among 17 trial sites for Oxford vaccine

IANS
Updated: August 4th, 2020, 10:38 IST
in National
0
Share on FacebookShare on TwitterShare on WhatsAppShare on Linkedin

Chandigarh: The PGI Hospital here is among the 17 trial sites in India for conducting the second and third phases of human clinical trials of Covishield, the potential vaccine developed by Oxford University, its director said Tuesday.

The trials would involve administration of the vaccine to 1,600 healthy adults across 17 sites.

Postgraduate Institute of Medical Education and Research (PGIMER) Director Jagat Ram said, “It’s an honour to be entrusted with this vital responsibility of being one of the sites for phase two and three trials on Covishield vaccine.

“The results of phase one trials in the UK have been encouraging and did not present any serious adverse side effects. Phase two and three trials will be done on a larger human population to see its efficacy and requisite protection against COVID-19 in humans.”

Further detailing, the Director added, “As the results of the trials will have far reaching impact, we will strengthen our capacities, wherever required, to come out with tangible outcomes.

“A core group will be constituted to work out the modalities and comprehensive plan along with timelines to meet the desired expectations of Drugs Controller General of India and contribute towards containing the pandemic to the best of our abilities.”

Earlier, a committee of experts on COVID-19 under Central Drugs Standard Control Organisation (CDSCO) had recommended the Drugs Controller General of India (DCGI) to grant approval to the Serum Institute of India (SII) for conducting the Phase two and three trials.

The permission was granted after the Serum institute satisfied certain requirements sought by the Drug Controller in the design of the proposal.

In addition to PGIMER Chandigarh, the other sites for trials include AIIMS in Delhi, ABJ Medical College in Pune, Rajendra Memorial Research Institute of Medical Sciences (RMRIMS) in Patna, AIIMS in Jodhpur, Nehru Hospital in Gorakhpur, Andhra Medical College in Visakhapatnam and JSS Academy of Higher Education and Research in Mysuru.

 

IANS

Tags: Covid vaccineCovishieldhuman clinical trialsOxford UniversityPGI HospitalPGI-Chandigarh
ShareTweetSendShare
Suggest A Correction

Enter your email to get our daily news in your inbox.

Related Posts

Bihar class 12 girl

Bihar: Class 12 girl jumps off building in suicide bid after failing exam; gets saved

October 1, 2023
Assam Rifles

AFSPA extended in four districts in Assam, withdrawn from four others: DGP

October 1, 2023
Manipur student killed

CBI detains four people in connection with murder of two teenagers in Manipur

October 1, 2023
Droupadi Murmu

Mahatma Gandhi’s strong, vibrant ideology will always remain relevant for world: Prez Droupadi Murmu

October 1, 2023
Vice Admiral Tarun Sobti taking charge as deputy chief from Vice Admiral Sanjay Mahindru

Vice Admiral Tarun Sobti takes charge as Deputy Chief of Naval Staff

October 1, 2023

GST mop-up rises 10% to over Rs 1.62 lakh cr in Sep; crosses Rs 1.60 lakh cr mark fourth time in FY 2024

October 1, 2023

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

OrissaPOST epaper Sunday POST OrissaPOST epaper

Click Here: Plastic Free Odisha

No Content Available

Archives

Editorial

Discrimination

October 1, 2023

Four centuries ago, the ambassador Sir Henry Wotton defined a diplomat as “an honest gentleman sent to lie abroad for...

Read more

Inspirational Tale

September 30, 2023

Transfers are an essential tool for the government to maintain control. However, frequent transfers of babus, especially those who perform...

Read more

Only Brave Talk

September 27, 2023

When China’s President Xi Jinping told the International Olympic Committee chief Thomas Bach in Hangzhou a day before the opening...

Read more

Road Tragedy

September 26, 2023

The recent late night road mishap that resulted in the death of a young medical practitioner Dr Amit Bisoi on...

Read more
  • Home
  • State
  • Metro
  • National
  • International
  • Business
  • Opinion
  • Feature
  • Sports
  • Sci-Tech
  • About Us
  • Advertise
  • Contact Us
  • Career
Developed By Ratna Technology

© 2020 All rights Reserved by OrissaPOST

  • Home
  • Metro
  • State
  • National
  • International
  • Sports
  • Business
  • Entertainment
  • Feature
  • Opinion
  • Sci-Tech
  • COVID-19
  • Today’s Pic
  • About Us
  • Contact Us
  • Career
  • Facebook
  • Twitter

© 2020 All rights Reserved by OrissaPOST